← SynDRA
ENOCITABINE
SynDRA canonical compound SYN0032268 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | CMPK1 | POLA1 | POLB | RRM1 | TYMS |
|---|
| Mechanism of action | DNA synthesis inhibitor |
|---|
| Indication | acute myeloid leukemia (AML) |
|---|
| Disease area | hematologic malignancy |
|---|
All known targets
- CMPK1
- POLA1
- POLB
- RRM1
- TYMS
Mechanisms of action (all sources)
Drug classes
- Nucleic Acid Synthesis Inhibitors
- Anti-Infective Agents
- Antineoplastic Agents
- Antiviral Agents
- Antimetabolites
- Antimetabolites, Antineoplastic
- Immunologic Factors
- Immunosuppressive Agents
- Noxae
- Nucleoside Metabolic Inhibitor
Cross-references
Synonyms
- behenoylcytosine arabinoside
- sunrabin
- Enocitabina
- Sunrabin
- NSC-239336
- Sunrabin (TN)
- NSC 239336
- 9YVR68W306
- NCGC00167515-01
- Behenoylcytosine arabinoside
- Enocitabinum
- Enocitabine [INN:JAN]
- BHAC
- Enocitabinum [INN-Latin]
- Enocitabina [INN-Spanish]
- N-(1-((2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)docosanamide
- N(sup 4)-Behenoylcytosine arabinoside
- BRN 0772101
- UNII-9YVR68W306
- N(sup 4)-Behenoyl-1-beta-D-arabinofuranosylcytosine
- Enocitabine (JAN/INN)
- ENOCITABINE [MI]
- ENOCITABINE [INN]
- ENOCITABINE [JAN]
- N(4)-behenoyl-1-beta-arabinofuranosylcytosine
- n4-behenoyl-1-beta-d-arabinofuranosylcytosine
- N-(1-beta-D-Arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)docosanamide
- SCHEMBL7962
- ENOCITABINE [MART.]
- ENOCITABINE [WHO-DD]
- CHEMBL2106589
- DTXSID6046682
- SCHEMBL21051876
- CHEBI:31537
- EX-A2055
- ZINC8214554
- Tox21_112513
- AKOS016014098
Look up ENOCITABINE in the interactive SynDRA portal →